The pulmonary arterial hypertension treatment market has witnessed a significant transformation in recent years, driven by advancements in medical research and increasing awareness about rare ...

A Hundred Experts Urge Strengthening Early Diagnosis of Pulmonary Hypertension in Latin America ...

Halo Biosciences ("Halo"), a clinical-stage biotechnology company developing extracellular matrix-targeted therapies, today ...

A relatively new therapy used to treat pulmonary arterial hypertension in those with mild to moderate disease was found to be ...

Pulmonary hypertension (PH) is a rare, progressive, debilitating condition characterised by elevated pulmonary artery ...

Panelists discuss how the pathophysiology of pulmonary arterial hypertension involves complex mechanisms across multiple ...

Kauvery Hospital launches Pulmonary Hypertension clinic for comprehensive care, early diagnosis, and multidisciplinary ...

Background Pulmonary hypertension (PH) is a progressive cardiopulmonary condition associated with increased morbidity and ...

The spring meeting of the Irish Society for Rheumatology brought together experts from across Ireland and the UK to highlight ...

Keros will be down to 85 full-time employees after the layoffs and expects to generate annualized savings of $17 million.

YUTREPIA now available to be prescribed to patients via specialty pharmaciesFDA approved YUTREPIA on May 23, 2025Court denies United Therapeutics’ request for preliminary injunction and a temporary ...

Findings from surveys of women with pulmonary arterial hypertension (PAH) include that 20% of health care providers were ...